|
PharmEng
receives site license from Health Canada to manufacture natural health products for the facility in Sydney, Nova Scotia
MORE
PharmEng
receives Establishment License from Health Canada for new facility in Sydney, Nova Scotia
MORE
PharmEng
relocates Perth, Ontario pharmaceutical contract manufacturing operations to new facility in Sydney, Nova Scotia
MORE
PharmEng
reports first quarter earnings for 2008
MORE
PharmEng
reports earnings for 2007
MORE
PharmEng
names John Durham as Corporate Vice President, Business Development, Keata Pharma Inc.
MORE
PharmEng
names John Carkner as President, Keata Pharma Arnprior, Ontario facility
MORE
PharmEng
completes acquisition of Pfizer manufacturing facility, announces closing of $20 million debt financing and full payout of amounts owing to Shropshire S.a.r.L.
MORE
PharmEng
announces purchase of Pfizer manufacturing facility in Arnprior, ONT.
MORE
PharmEng
reports third quarter earnings for 2007
MORE
PharmEng
announces opening of pharmaceutical manufacturing facility in Cape Breton, N.S.
MORE
PharmEng
International Inc. announces full payout of Laurus obligation
MORE
Shropshire S.ΐ R.L exercises warrants of PharmEng International inc.
MORE
PharmEng
names David G. Leonard as President Keata Pharma
MORE
PharmEng
announces completion of final tranche of private placement
MORE
PharmEng
International Inc. closes China acquisition
MORE
PharmEng
reports earnings for 2006
MORE
PharmEng
International Inc. completes additional $3 M private placement financing
MORE
PharmEng
International Inc. closes private placement financing
MORE
PharmEng
announces exclusive agreement with Chinese manufacturer for distribution of acetaminophen to North America resulting in significant raw material cost savings
MORE
PharmEng
announces opening of San Francisco offices with $1.6 M (US) in 2006 contracts and completion of the biopharmaceutical certificate program in Taiwan
MORE
PharmEng
issues securities in connection with private placements
MORE
PharmEng reports third quarter earnings for 2006
MORE
PharmEng
names Bert Loveless As Chief Financial Officer
Bernie Boudreau elected To The Board
MORE
PharmEng reports Second Quarter Earnings for 2006
MORE
PharmEng announces Board Changes
MORE
PharmEng International Inc. completes Financings
MORE
PharmEng starts Training Program in Taiwan in Collaboration With The
University of Waterloo and The National Research Institute.
MORE
PharmEng extends Vertical Intergration Strategy and Acquires Laboratory
Instru-mentation Solution Services Company
MORE
PharmEng International Inc. announces Extension Of Warrant Term For 2004
Warrants
MORE
PharmEng names Lawrence Tjan as Chief Financial Officer
MORE
PharmEng reports earnings for 2005
MORE
Euro-Pharm selects PharmEng as private label supplier
MORE
PharmEng signs Letter of Intent to purchase Beijing pharmaceutical
consulting company
MORE
Pirri selects PharmEng as exclusive supplier
MORE
Tanta selects PharmEng as strategic supplier
MORE
MEDEC PULSE magazine posted our new manufacturing facility in Nova Scotia
MORE
PharmEng offices, announces opening of Halifax office
MORE
PharmEng named to TSX Venture 50
MORE
Pictures of Sod Turning Ceremony in Cape Breton, N.S.
MORE
Sod Turning Ceremony marks start of construction of first pharmaceutical
manufacturing facility in Cape Breton, N.S.
MORE
PharmEng opens offices, announces $1.7M U.S. contract in Raleigh, North
Carolina
MORE
2005 NHP Vancouver Training.
MORE
PharmEng announces manufacturing contracts.
MORE
PharmEng reports second quarter earnings for 2005.
MORE
PharmEng closes final tranche of private placement.
MORE
PharmEng adds to Senior Management Team.
MORE
PharmEng releases strong 2004 results.
MORE
PharmEng acquires platform for new manufacturing capacity.
MORE
Chrysalis Capital Corporation closes business combination with PharmEng.
MORE
PharmEng Receives Best International Business Award.
MORE
NEWS ARCHIVE
Biosciences Eastern & Central Africa Environmental
Assessment Project
|
